MAPK3 and cancer: As illustrated in Figure 8, FF may exert its anti-cancer effects by inhibiting the IL-17B-IL17RB signaling axis and concurrently reducing the phosphorylation levels of downstream signaling molecules ERK1/2 and P38 MAPK.